Jinyu Bio-technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,609	1,265	1,140	1,712	1,405	1,334
Trading Asset Securities	61.15	120.11	36.83	37.27	46.94	183.85
Cash & Short-Term Investments	1,670	1,385	1,176	1,749	1,452	1,518
Cash Growth	52.33%	17.74%	-32.76%	20.46%	-4.32%	-29.58%
Accounts Receivable	806.47	601.17	648.83	869.84	816.65	742.88
Other Receivables	47.23	63.98	45.14	44.37	57.29	41.49
Receivables	853.7	665.15	693.97	914.21	873.94	904.5
Inventory	264.37	269.13	294.64	322.25	333.46	317.65
Prepaid Expenses	-	0.01	3.49	3.45	-	1.07
Other Current Assets	35.5	24.4	22.93	26.51	20.91	19.4
Total Current Assets	2,824	2,344	2,191	3,016	2,681	2,761
Property, Plant & Equipment	1,806	1,887	1,830	1,892	1,799	1,819
Long-Term Investments	951.89	1,305	1,829	1,025	1,019	1,058
Goodwill	139.18	8.2	8.2	11.41	29.49	94.5
Other Intangible Assets	522.82	572.27	586.76	352.12	347.32	388.45
Long-Term Deferred Tax Assets	130.39	126.54	107.36	96.99	83.43	86.15
Long-Term Deferred Charges	149.72	118.43	69.84	378.12	322.53	260.16
Other Long-Term Assets	93.37	250.28	142.28	100.48	107.87	136.86
Total Assets	6,617	6,612	6,765	6,873	6,389	6,604

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	291.1	256.02	295.84	324.41	354.41	347.05
Accrued Expenses	60.9	73.3	58.85	76.96	101.36	102.82
Short-Term Debt	0.45	-	15.01	-	10.01	-
Current Portion of Leases	0.67	1.43	1.48	1.53	0.53	0.62
Current Income Taxes Payable	7.89	9.98	4.07	6.92	13.39	7.82
Current Unearned Revenue	102.52	101.45	105.14	98.38	84.65	82.55
Other Current Liabilities	206.64	278.36	244.67	332.25	94.39	148.29
Total Current Liabilities	670.18	720.53	725.06	840.45	658.75	689.15
Long-Term Debt	100	-	-	-	-	-
Long-Term Leases	0.15	0.15	1.25	2.73	0.31	0.16
Long-Term Unearned Revenue	310.01	331.75	345.32	364.84	370.49	343.9
Long-Term Deferred Tax Liabilities	7.45	8.29	9.36	9.63	10.15	10.48
Other Long-Term Liabilities	3	-	268.29	-	-	-
Total Liabilities	1,091	1,061	1,349	1,218	1,040	1,044

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,112	1,112	1,120	1,120	1,120	1,126
Additional Paid-In Capital	764.49	751.85	764.9	891.52	834.3	893.34
Retained Earnings	3,864	3,800	3,693	3,673	3,456	3,366
Treasury Stock	-275.62	-242.3	-209.67	-338.48	-338.48	-113.34
Comprehensive Income & Other	-53.16	-53.16	-53.9	20.46	-0.41	-0.23
Total Common Equity	5,411	5,368	5,314	5,367	5,072	5,272
Minority Interest	114.96	182.81	101.04	288.06	277.45	287.98
Shareholders' Equity	5,526	5,551	5,415	5,655	5,350	5,560
Total Liabilities & Equity	6,617	6,612	6,765	6,873	6,389	6,604

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	101.28	1.58	17.74	4.27	10.85	0.78
Net Cash (Debt)	1,569	1,383	1,159	1,745	1,442	1,517
Net Cash Growth	45.37%	19.41%	-33.61%	21.07%	-4.99%	-29.61%
Net Cash Per Share	1.39	1.24	1.06	1.60	1.30	1.35
Filing Date Shares Outstanding	1,090	1,223	1,117	1,117	1,087	1,103
Total Common Shares Outstanding	1,090	1,223	1,117	1,117	1,087	1,103
Working Capital	2,153	1,623	1,466	2,175	2,022	2,071
Book Value Per Share	4.96	4.39	4.76	4.80	4.66	4.78
Tangible Book Value	4,749	4,788	4,719	5,003	4,695	4,789
Tangible Book Value Per Share	4.36	3.91	4.22	4.48	4.32	4.34
Buildings	1,297	1,301	1,274	1,153	1,152	1,128
Machinery	1,459	1,461	1,451	1,354	50.02	1,272
Construction In Progress	363.29	365.22	201.48	359.22	151.72	128.74